MX2020007064A - Preparacion de barrera para la piel y metodo para esta. - Google Patents

Preparacion de barrera para la piel y metodo para esta.

Info

Publication number
MX2020007064A
MX2020007064A MX2020007064A MX2020007064A MX2020007064A MX 2020007064 A MX2020007064 A MX 2020007064A MX 2020007064 A MX2020007064 A MX 2020007064A MX 2020007064 A MX2020007064 A MX 2020007064A MX 2020007064 A MX2020007064 A MX 2020007064A
Authority
MX
Mexico
Prior art keywords
skin barrier
method therefor
barrier preparation
preparation
skin
Prior art date
Application number
MX2020007064A
Other languages
English (en)
Inventor
Thierry Oddos
Jalil Bensaci
Georgios N Stamatas
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MX2020007064A publication Critical patent/MX2020007064A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/28—Investigating the spectrum
    • G01J3/44—Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/0078—Testing material properties on manufactured objects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
    • G06F16/24—Querying
    • G06F16/245—Query processing
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F30/00—Computer-aided design [CAD]
    • G06F30/20—Design optimisation, verification or simulation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/28—Investigating the spectrum
    • G01J2003/2866—Markers; Calibrating of scan

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Primary Health Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)

Abstract

Se describe un metodo para seleccionar un sistema de barrera para la piel adecuado para infantes y niños pequeños.
MX2020007064A 2018-01-05 2018-12-14 Preparacion de barrera para la piel y metodo para esta. MX2020007064A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862613878P 2018-01-05 2018-01-05
PCT/IB2018/060130 WO2019135129A1 (en) 2018-01-05 2018-12-14 Skin barrier preparation and method therefor

Publications (1)

Publication Number Publication Date
MX2020007064A true MX2020007064A (es) 2020-09-09

Family

ID=65365985

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020007069A MX2020007069A (es) 2018-01-05 2018-12-14 Preparación de barrera para la piel y método para esta.
MX2020007064A MX2020007064A (es) 2018-01-05 2018-12-14 Preparacion de barrera para la piel y metodo para esta.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2020007069A MX2020007069A (es) 2018-01-05 2018-12-14 Preparación de barrera para la piel y método para esta.

Country Status (11)

Country Link
US (2) US11090393B2 (es)
EP (2) EP3735700A1 (es)
JP (2) JP7317838B2 (es)
KR (1) KR102697021B1 (es)
CN (2) CN111566754B (es)
AU (2) AU2018399218B2 (es)
BR (2) BR112020013593A8 (es)
CA (2) CA3086656A1 (es)
MX (2) MX2020007069A (es)
WO (2) WO2019135128A1 (es)
ZA (1) ZA202004823B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11229595B2 (en) * 2019-05-29 2022-01-25 Johnson & Johnson Consumer Inc. Skin barrier preparation and method therefor
JP7309765B2 (ja) * 2021-03-04 2023-07-18 花王株式会社 経皮吸収量の推定方法
EP4402644A1 (en) 2021-09-16 2024-07-24 Johnson & Johnson Consumer Inc. Analysis and characterization of epithelial tissue structure
KR20240138109A (ko) 2022-01-28 2024-09-20 존슨 앤드 존슨 컨수머 인코포레이티드 아토피성 피부염을 예측하는 바이오마커
WO2023194839A1 (en) 2022-04-04 2023-10-12 Donnelly Window of opportunity skin treatment regimen and composition for preventing the onset of or treating atopic dermatitis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69735354T2 (de) * 1996-10-28 2006-11-30 Amersham Health As Verbesserungen an oder in verbindung mit diagnostischen/therapeutischen verbindungen
US6151717A (en) 1999-07-20 2000-11-28 Aearo Company Transparent or translucent earmuff cup
WO2001053444A1 (en) 2000-01-20 2001-07-26 The Procter & Gamble Company Antimicrobial compositions
CN1506042A (zh) * 2002-12-11 2004-06-23 苏加璐 使用来自胎儿细胞和组织的化合物改善皮肤状况的方法和组合物
US20070238941A1 (en) * 2006-03-28 2007-10-11 Janeta Nikolovski Methods and devices for evaluating skin
JP5608282B2 (ja) * 2010-04-05 2014-10-15 イー・エム・デイー・ミリポア・コーポレイシヨン ヒト皮膚様透過性を有するポリマー膜およびこの使用
JP5946699B2 (ja) * 2012-06-01 2016-07-06 花王株式会社 水分透過バリア機能の評価方法
FR2993282B1 (fr) * 2012-07-13 2017-11-10 Expanscience Lab Procede d'identification de marqueurs moleculaires de la peau d'enfant
WO2014028569A1 (en) 2012-08-15 2014-02-20 The Procter & Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating an array of skin disorders
US9256963B2 (en) * 2013-04-09 2016-02-09 Elc Management Llc Skin diagnostic and image processing systems, apparatus and articles
JP6147608B2 (ja) 2013-08-20 2017-06-14 日本メナード化粧品株式会社 Ｘ線回折を利用した皮膚浸透性評価法
CN103785064B (zh) * 2013-08-26 2015-02-25 济南磐升生物技术有限公司 一种皮肤模型及应用
FR3019186B1 (fr) * 2014-03-31 2019-06-07 Laboratoires Expanscience Procedes d'evaluation des effets deleteres de l'urine sur la peau d'enfant
CN104376221B (zh) * 2014-11-21 2018-06-15 环境保护部南京环境科学研究所 一种预测有机化学品的皮肤渗透系数的方法
FR3045669B1 (fr) 2015-12-16 2019-04-05 Laboratoires Expanscience Procedes d'evaluation des effets de la deshydratation sur la peau d'enfant
US20180185255A1 (en) 2017-01-05 2018-07-05 The Procter & Gamble Company Method of Selecting Mild Skin Cleansers
EP3370178A3 (en) * 2017-03-03 2018-12-19 Tata Consultancy Services Limited Method and system for in silico testing of actives on human skin

Also Published As

Publication number Publication date
JP2021509954A (ja) 2021-04-08
EP3735701A1 (en) 2020-11-11
US11744905B2 (en) 2023-09-05
CA3086684A1 (en) 2019-07-11
CN111602207B (zh) 2024-10-01
CN111566754A (zh) 2020-08-21
AU2018399218A1 (en) 2020-07-02
JP7314148B2 (ja) 2023-07-25
BR112020013544A2 (pt) 2020-12-01
RU2020125674A3 (es) 2022-02-07
AU2018399218B2 (en) 2024-02-22
AU2018399217B2 (en) 2024-09-26
RU2020125673A3 (es) 2022-04-29
RU2020125673A (ru) 2022-02-07
MX2020007069A (es) 2021-01-15
BR112020013593A2 (pt) 2020-12-01
CN111602207A (zh) 2020-08-28
WO2019135129A1 (en) 2019-07-11
JP2021510199A (ja) 2021-04-15
KR102697021B1 (ko) 2024-08-22
ZA202004823B (en) 2023-05-31
AU2018399217A1 (en) 2020-07-09
KR20200106919A (ko) 2020-09-15
CN111566754B (zh) 2024-08-30
US20190212324A1 (en) 2019-07-11
US20190209711A1 (en) 2019-07-11
WO2019135128A1 (en) 2019-07-11
KR20200106519A (ko) 2020-09-14
RU2020125674A (ru) 2022-02-07
BR112020013544A8 (pt) 2022-07-26
BR112020013593A8 (pt) 2022-07-26
US11090393B2 (en) 2021-08-17
CA3086656A1 (en) 2019-07-11
JP7317838B2 (ja) 2023-07-31
EP3735700A1 (en) 2020-11-11

Similar Documents

Publication Publication Date Title
MX2020007064A (es) Preparacion de barrera para la piel y metodo para esta.
BR112018006243A2 (pt) formas de cristal de mononucleotídeo de beta-nicotinamida
GB2583687B (en) Method and system for generating a 3D reconstruction of a human
MX2017016900A (es) Método y aparato para el soporte extracorpóreo del feto prematuro.
MY192714A (en) Antibody neutralizing human respiratory syncytial virus
HUE062341T2 (hu) Kereszt-komponenses lineáris model egyszerûsítése
DK2970377T3 (da) Fremgangsmåder til fremstilling af et humant plasma-afledt igg-præparat beriget med hjernesygdom-relaterede naturlige igg'er
BR112016013562A2 (pt) Anticorpos anti-tau(ps422) humanizados, seus usos, e formulações farmacêuticas
MX2021014570A (es) Método para seleccionar un sistema de barrera para la piel adecuado para infantes y niños pequeños.
EP3127517A4 (en) Method for producing stretchable structure for absorbent article, method for producing pants-type disposable diaper, and pants-type disposable diaper
EP3432974A4 (en) SYSTEM AND METHOD FOR DELETING VESTIBULAR ACTIVITY FROM A HUMAN SUBJECT
EP3891677A4 (en) SYSTEM AND PROCEDURE FOR PHARMACEUTICAL OPERATIONS FOR POST-ACUTE CARE FACILITIES AND LONG-TERM CARE FACILITIES
CR20210158A (es) Formas de dosificación pediátricas de vitamina d, métodos de elaboración y uso
EP3823620A4 (en) OPIOID HAPTENES, CONJUGATES, VACCINES AND METHODS OF GENERATING ANTIBODIES
EP3749291A4 (en) BLOOD-ENCEPHALIC BARRIER PERMEABILIZATION PROCESSES
EP3496825A4 (en) ADJUSTING SYSTEM FOR NATURAL MARKET THERAPY WITH SIMULATED ASSISTANCE
MX2015017257A (es) Composiciones y metodos de inmunizar contra clostridium difficile.
CA205117S (en) Child chair
EP3448391A4 (en) METHODS OF TREATING DISEASES IN WHICH IL-13 ACTIVITY IS HARMFUL WITH ANTI-IL-13 ANTIBODIES
CA161832S (en) Licorice bracelet teething toy for infant
CA161830S (en) Bacon strips teething toy for infant
EP4057808A4 (en) HUMANIZED MOUSE MODEL WITH HUMAN IMMUNE SYSTEM
EP3875096A4 (en) METHOD OF PREPARING A BLOOD PRODUCT AND BLOOD PRODUCT
EP3643237C0 (en) METHOD AND SYSTEM FOR DETERMINING THE TRUSTWORTHINESS OF A PERSON USING AN ELECTROENCEPHALOGRAM
GB201909685D0 (en) Infant highchair